Clinical Trial

A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma

Recruiting
View on ClinicalTrials.gov →
Summary
By comparing the diagnostic accuracy of spectral CT and conventional CT in evaluating treatment response efficacy after TACE, this study aims to investigate the diagnostic performance of spectral CT in assessing treatment response following TACE for hepatocellular carcinoma.
Protocol Amendment History 1 change
notable Enrollment reduced: 250 -> 121 participants 2026-06-11
Trial Details
NCT Number NCT07351669
Lead Sponsor Zhongda Hospital
Conditions HCC - Hepatocellular Carcinoma, TACE(Transcatheter Arterial Chemoembolization), CT
Enrollment 121 participants
Start Date 2026-01-20
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-10